Prot #1199-0324: Study of Pulmonary Rehabilitation In Nintedanib Treated Patients with IPF: Improvements in Activity, Exercise Endurance Time, and QoL

Project: Research project

StatusActive
Effective start/end date2/28/192/28/22

Funding

  • Boehringer Ingelheim Pharmaceuticals, Inc. (Prot #1199-0324)